ASM8 / Syntara - LARVOL DELTA

Safety and Efficacy of Two Dosages of Inhaled TPI ASM8 Compared to Placebo in Mild to Moderate Asthmatic Patients (clinicaltrials.gov) - P2; N=10; Terminated; Sponsor: Pharmaxis; N=60 ➔ 10

Clinical • Enrollment change